无症状绝经后妇女子宫内膜癌风险与超声子宫内膜厚度的系统评价与诊断准确性Meta分析
本系统评价与诊断准确性Meta分析纳入18项研究共10334例无症状绝经后妇女,评估经阴道超声子宫内膜厚度阈值与子宫内膜癌及非典型子宫内膜增生的风险。结果显示,子宫内膜厚度≥3.0 mm时风险增加约3倍(RR 3.77),各阈值亚组间无显著差异(P=.885);3.0–5.9 mm阈值敏感性较高但特异性较低,作者认为该阈值可用于进一步子宫内膜评估。
要点
- 无症状绝经后妇女子宫内膜厚度≥3.0 mm时,子宫内膜癌或非典型增生风险约为低于阈值者的3.77倍(95%CI 2.26-6.32)。
- 各厚度阈值亚组(3.0–5.9、6.0–9.9、10.0–13.9、≥14.0 mm)间风险无显著差异(P=.885)。
- 3.0–5.9 mm阈值敏感性较高但特异性较低,作者认为可用于疑似子宫内膜恶性患者的进一步评估。
核心结论
- 无症状绝经后妇女中,低与高子宫内膜厚度阈值在检测子宫内膜癌和非典型子宫内膜增生方面似乎同样有效。
- 尽管3.0–5.9 mm阈值特异性较低,但敏感性的提升可能支持将该阈值用于疑似子宫内膜恶性患者的进一步子宫内膜评估。
研究设计与样本
- 系统评价与诊断准确性Meta分析,遵循PRISMA-DTA和SEDATE指南。
- 检索MEDLINE、Scopus、ClinicalTrials.gov、SciELO、Embase、Cochrane CENTRAL、LILACS、会议论文集及国际对照试验注册库,无时间、地域或语言限制。
- 纳入标准为交叉设计、评估无症状绝经后妇女子宫内膜非典型增生和癌风险、计算经阴道超声阈值(至少3.0 mm)并经组织病理学确诊的诊断准确性研究。
- 最终纳入18项研究,共10334例妇女。
- 采用QUADAS-2工具进行质量评价,Deek漏斗图检验量化发表偏倚。
主要发现
- 子宫内膜厚度≥3.0 mm时,非典型子宫内膜增生或子宫内膜癌风险相对低于阈值者增加约3倍(RR 3.77,95%CI 2.26-6.32,I²=74%)。
- 3.0–5.9 mm阈值RR 5.08(95%CI 2.26-11.41,I²=0%),6.0–9.9 mm阈值RR 4.34(95%CI 1.68-11.23,I²=0%),10.0–13.9 mm阈值RR 4.11(95%CI 1.55-10.87,I²=86%),≥14.0 mm阈值RR 2.53(95%CI 1.04-6.16,I²=78%),亚组间无显著差异(P=.885)。
- 合并敏感性从低于5.9 mm阈值(RR 0.81,95%CI 0.49-0.85)降至高于14.0 mm阈值(RR 0.28,95%CI 0.18-0.40)。
- 特异性从3.0–5.9 mm阈值的0.70(95%CI 0.61-0.78)升高至≥14.0 mm阈值的0.86(95%CI 0.71-0.94)。
- 3.0–5.9 mm和10.0–13.9 mm阈值的诊断比值比最高,分别为10(95%CI 3-41)和11(95%CI 2-49),曲线下面积分别为0.81(95%CI 0.77-0.84)和0.82(95%CI 0.79-0.86)。
关键数值与推荐
- 子宫内膜厚度阈值分组:3.0–5.9 mm;6.0–9.9 mm;10.0–13.9 mm;≥14.0 mm。
- 总体阈值≥3.0 mm时,非典型子宫内膜增生或子宫内膜癌风险RR 3.77(95%CI 2.26-6.32,I²=74%)。
- 3.0–5.9 mm阈值RR 5.08(95%CI 2.26-11.41,I²=0%)。
- 6.0–9.9 mm阈值RR 4.34(95%CI 1.68-11.23,I²=0%)。
- 10.0–13.9 mm阈值RR 4.11(95%CI 1.55-10.87,I²=86%)。
临床怎么用
- 作者认为,尽管3.0–5.9 mm截断点特异性较低,但敏感性的提升可能支持将该截断点用于疑似子宫内膜恶性患者的进一步子宫内膜评估。
局限性
- 总体阈值≥3.0 mm分析的异质性I²=74%。
- 10.0–13.9 mm阈值分析的异质性I²=86%。
- ≥14.0 mm阈值分析的异质性I²=78%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to evaluate the risk of endometrial carcinoma and atypical endometrial hyperplasia in asymptomatic postmenopausal women concerning the endometrial thickness measured by stratified threshold categories used for performing subsequent endometrial sampling and histologic evaluation. DATA SOURCES: MEDLINE, Scopus, ClinicalTrials.gov, SciELO, Embase, the Cochrane Central Register of Controlled Trials, LILACS, conference proceedings, and international controlled trials registries were searched without temporal, geographic, or language restrictions. STUDY ELIGIBILITY CRITERIA: Studies were selected if they had a crossover design evaluating the risk of atypical endometrial hyperplasia and endometrial carcinoma in postmenopausal asymptomatic women and calculated the diagnostic accuracy of transvaginal ultrasonography thresholds (at least 3.0 mm) confirmed by histopathologic diagnosis. METHODS: This was a systematic review and diagnostic test accuracy meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses of Diagnostic Test Accuracy and Synthesizing Evidence from Diagnostic Accuracy Tests guidelines. Endometrial thickness thresholds were grouped as follows: from 3.0 to 5.9 mm; between 6.0 and 9.9 mm; between 10.0 and 13.9 mm; and ≥14.0 mm. Quality assessment was performed using the Quality Assessment Tool for Diagnostic Accuracy Studies 2 tool. Publication bias was quantified using the Deek funnel plot test. Coprimary outcomes were the risk of atypical endometrial hyperplasia or endometrial carcinoma according to the endometrial thickness and diagnostic accuracy of each threshold group. RESULTS: A total of 18 studies provided the data of 10,334 women who were all included in the final analysis. Overall, at an endometrial thickness threshold of at least 3.0 mm, the risk of atypical endometrial hyperplasia or endometrial carcinoma was increased 3-fold relative to women below the cutoff (relative risk, 3.77; 95% confidence interval, 2.26-6.32; I2=74%). Similar degrees of risk were reported for thresholds between 3.0 and 5.9 mm (relative risk, 5.08; 95% confidence interval, 2.26-11.41; I2=0%), 6.0 and 9.9 mm (relative risk, 4.34; 95% confidence interval, 1.68-11.23; I2=0%), 10.0 and 13.9 mm (relative risk, 4.11; 95% confidence interval, 1.55-10.87; I2=86%), and ≥14.0 mm (relative risk, 2.53; 95% confidence interval, 1.04-6.16; I2=78%) with no significant difference among subgroups (P=.885). Regarding diagnostic accuracy, the pooled sensitivity decreased from thresholds below 5.9 mm (relative risk, 0.81; 95% confidence interval, 0.49-0.85) to above 14.0 mm (relative risk, 0.28; 95% confidence interval, 0.18-0.40). Furthermore, the specificity increased from 0.70 (95% confidence interval, 0.61-0.78) for endometrial thickness between 3.0 and 5.9 mm to 0.86 (95% confidence interval, 0.71-0.94) when the endometrial thickness is ≥14.0 mm. For 3.0 to 5.9 mm and 10.0 to 13.9 mm thresholds, the highest diagnostic odds ratios of 10 (95% confidence interval, 3-41) and 11 (95% confidence interval, 2-49), with areas under the curve of 0.81 (95% confidence interval, 0.77-0.84) and 0.82 (95% confidence interval, 0.79-0.86), respectively, were retrieved. The summary point analysis revealed that the 3.0 to 5.9 mm cutoff point was placed higher in the summary receiver operator curve space than the other subgroups, indicating increased endometrial carcinoma or atypical endometrial hyperplasia diagnosis using these cutoffs. CONCLUSION: Both low and high endometrial thickness thresholds in postmenopausal asymptomatic women seem equally effective in detecting endometrial carcinoma and atypical endometrial hyperplasia. However, although using a 3.0 to 5.9 mm cutoff results in a lower specificity, the offsetting improvement in sensitivity may justify using this cutoff for further endometrial evaluation in patients with suspected endometrial malignancy.
引用
- Vitale SG, Riemma G, Haimovich S, et al. Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness: systematic review and diagnostic test accuracy meta-analysis. Am J Obstet Gynecol. 2022. PMID: 35932873. doi:10.1016/j.ajog.2022.07.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。